Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN104797563B reveals improved in-situ synthesis of activated fumarate intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical excipient manufacturing.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.
Novel metal-free synthesis of functionalized allenones using N-heterocyclic carbene catalysts. Offers high atom economy and scalability for pharmaceutical intermediates.
Discover a catalyst-free thermal method for synthesizing alpha-amidoketones from patent CN111960961B. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118108623A reveals mild base-catalyzed route for N-O bonds. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110627693A reveals efficient allyl sulfone synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN114369053B reveals a metal-free route for high-purity sulfonylated pyrrolidone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102558004A reveals a mild, high-yield synthesis route for S-(4-tolyl)benzenesulfonate, offering significant cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN105153020A details a novel four-step synthesis route for aromatic azides offering significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthetic route for 7-chloro-2,2-dimethylheptanoate using 1-bromo-5-chloropentane. Achieves high purity, minimizes byproducts, and enables scalable manufacturing for lipid-lowering APIs.
Novel I2O5-mediated cyclization of diynes offers high-purity indanones with reduced environmental impact and simplified purification for pharmaceutical intermediates.
Patent CN110284149A details a green electrochemical route for mesocyclic lactams, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104892472A details a novel bis-chiral sulfoxide-alkene ligand synthesis enabling high-efficiency rhodium-catalyzed asymmetric allylation for pharmaceutical intermediate manufacturing.
Patent CN115584518A reveals a metal-free electrochemical route for N-alkyl amides. Offers mild conditions, high purity, and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel synthetic route for veranamine offers cost reduction in pharma intermediate manufacturing with scalable catalytic steps and high purity specifications for global supply chains.
Novel thiophosgene-free route for enzalutamide intermediates. Enhances supply chain safety and reduces genotoxic risks for pharmaceutical manufacturing partners globally.
Patent CN112795943A details a green electrochemical method for 3,4-dibromomaleimide, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114214646B details electrochemical synthesis avoiding toxic metals. Enables cost reduction and reliable supply chain for fine chemical intermediates.